AZDOR
DEAD

Serial Number

97396865

Owner

TEVA PHARMACEUTICALS USA, Inc.

Attorney

Lori Wolfe

Filing Date

May 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

AZDOR Trademark

Serial Number: 97396865

AZDOR is a trademark filed by TEVA PHARMACEUTICALS USA, Inc. on May 5, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

TEVA PHARMACEUTICALS USA, Inc.

Building A
Parsippany, NJ 07054

Entity Type: 03

Trademark Details

Filing Date

May 5, 2022

Registration Date

Not Registered

Published for Opposition

March 28, 2023

Goods & Services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations, namely, oral and injectable contraceptives, women's hormone replacement medications

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 18, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 18, 2026 COAR
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 29, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 29, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 15, 2025 EXRA
SOU EXTENSION 4 GRANTED
May 14, 2025 EX4G
SOU EXTENSION 4 FILED
May 14, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
May 14, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 19, 2024 EXRA
SOU EXTENSION 3 GRANTED
Nov 19, 2024 EX3G
SOU EXTENSION 3 FILED
Nov 19, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 19, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 1, 2024 EXRA
SOU EXTENSION 2 GRANTED
Apr 30, 2024 EX2G
SOU EXTENSION 2 FILED
Apr 30, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 30, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 22, 2024 EXRA
SOU EXTENSION 1 GRANTED
Feb 21, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 21, 2024 AITU
NOTICE OF REVIVAL - E-MAILED
Jan 4, 2024 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jan 4, 2024 TPEX
PETITION TO REVIVE-GRANTED
Jan 4, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jan 4, 2024 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 26, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 25, 2023 ABN6
SOU EXTENSION 1 FILED
Nov 23, 2023 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 23, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 28, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 28, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 8, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 17, 2023 CNSA
ASSIGNED TO EXAMINER
Feb 15, 2023 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 2, 2023 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Feb 2, 2023 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 2, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 2, 2023 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 7, 2022 REAP
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 10, 2022 NWOS
NEW APPLICATION ENTERED
May 9, 2022 NWAP